Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H2 | P55055 | 1/20 | 0.45 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.45 |
| ▸ | PGR | P06401 | 1/20 | 0.41 |
| ▸ | RORA | P35398 | 1/20 | 0.41 |
| ▸ | RORC | P51449 | 1/20 | 0.41 |
| ▸ | RORB | Q92753 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.40 |
| ▸ | CNR2 | P34972 | 4/20 | 0.39 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.39 |
| ▸ | HTR7 | P34969 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28680138 | 0.93 | NR1H2 (0.54) | NR1H2NR1H3PGRRORARORC | |
| SCHEMBL6280028 | 0.89 | GPR3 (0.43) | NR1H2NR1H3PGRRORARORC | |
| SCHEMBL21420902 | 0.83 | ALDH1A1 (0.52) | PGRRORARORCRORBALDH1A1 | |
| SCHEMBL27725662 | 0.83 | NR1H2 (0.43) | NR1H2NR1H3PGRRORARORC | |
| SCHEMBL262781 | 0.82 | GABRP (0.41) | NR1H2NR1H3ALDH1A1KDM4ECNR2 | |
| SCHEMBL1725649 | 0.81 | ALDH1A1 (0.40) | NR1H2NR1H3ALDH1A1KDM4ECYP1A2 | |
| SCHEMBL262720 | 0.80 | GABRP (0.44) | ALDH1A1KDM4ECYP1A2SMN1; SMN2HPGD | |
| SCHEMBL262341 | 0.79 | TSPO (0.37) | ALDH1A1KDM4ECYP1A2HTTCNR2 | |
| SCHEMBL262482 | 0.79 | TSPO (0.37) | ALDH1A1KDM4ECYP1A2HTTCNR2 | |
| SCHEMBL31305289 | 0.78 | FABP4 (0.54) | ALDH1A1KDM4ECYP1A2CYP2D6SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2937355-B1 | PHOSPHORUS COMPOUND AND TRANSITION METAL COMPLEX OF THE SAME | TAKASAGO PERFUMERY CO LTD (JP) | 2017-06-28 | — | — | EP | disclosed |
| EP-2937355-B1 | PHOSPHORUS COMPOUND AND TRANSITION METAL COMPLEX OF THE SAME | TAKASAGO PERFUMERY CO LTD (JP) | 2017-06-28 | — | — | EP | disclosed |
| US-9416148-B2 | Phosphorus compound and transition metal complex of the same | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2016-08-16 | — | — | US | disclosed |
| US-9416148-B2 | Phosphorus compound and transition metal complex of the same | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2016-08-16 | — | — | US | disclosed |
| US-9416148-B2 | Phosphorus compound and transition metal complex of the same | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2016-08-16 | — | — | US | disclosed |
| US-20150307531-A1 | PHOSPHORUS COMPOUND AND TRANSITION METAL COMPLEX OF THE SAME | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2015-10-29 | — | — | US | disclosed |
| US-20150307531-A1 | PHOSPHORUS COMPOUND AND TRANSITION METAL COMPLEX OF THE SAME | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2015-10-29 | — | — | US | disclosed |
| US-20150307531-A1 | PHOSPHORUS COMPOUND AND TRANSITION METAL COMPLEX OF THE SAME | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2015-10-29 | — | — | US | disclosed |
| EP-2937355-A1 | PHOSPHORUS COMPOUND AND TRANSITION METAL COMPLEX OF THE SAME | Takasago International Corporation (JP) | 2015-10-28 | — | — | EP | disclosed |
| EP-2937355-A1 | PHOSPHORUS COMPOUND AND TRANSITION METAL COMPLEX OF THE SAME | Takasago International Corporation (JP) | 2015-10-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150307531-A1 | PHOSPHORUS COMPOUND AND TRANSITION METAL COMPLEX OF THE SAME | P2RY10, PTH1R, INPP5A | NR1H2 3823/4885NR1H3 3860/4885PGR 53/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.